Sanara MedTech Inc. reported $110M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $110M (to Q2 2026). Net income: −$32M, trailing twelve months to Q2 2026. Free cash flow: $4.5M, trailing twelve months to Q2 2026. Operating margin: 7.7%, trailing twelve months to Q2 2026.

SMTISanara MedTech Inc.

Healthcare

$35.04+16% 1Y

$35.04

$16.3452 weeks$35.26

SMTI as reported

Sanara MedTech Inc. reported $110M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed.

$110M

Revenue, trailing twelve months · to Q2 2026 · +13% against the twelve months before

Net income: −$32M
Net income · +222% year on year · trailing twelve months to Q2 2026
Free cash flow: $4.5M
Free cash flow · +5368% year on year · trailing twelve months to Q2 2026
Operating margin: 7.7%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SMTI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$110M	+13%	Q2 2026
Net income	−$32M	+222%	Q2 2026
EPS	−$3.72	+221%	Q2 2026
Gross margin	93%	n/a	Q2 2026
Operating margin	7.7%	n/a	Q2 2026
Net margin	−30%	n/a	Q2 2026
ROE	−531%	n/a	Q2 2026
ROA	−50%	n/a	Q2 2026
ROIC	18%	n/a	Q2 2026
Free cash flow	$4.5M	+5368%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.